作者：
Nagtegaal,G.J.A. [1]
;
Pohl,C. [2]
;
Wattjes,M.P. [3]
;
Hulst,H.E. [4]
;
Freedman,M.S. [5]
;
Hartung,H.-P. [6]
;
Miller,D. [7]
;
Montalban,X. [8]
;
Kappos,L. [9]
;
Edan,G. [10]
;
Pleimes,D. [11]
;
Beckman,K. ;
Stemper,B. ;
Polman,C.H. ;
Sandbrink,R. ;
Barkhof,F.
作者单位：
Global Clinical Development, Bayer Pharma AG, Germany, Department of Neurology, University Hospital
[1]
Department of Neurology, University of Basel, University Hospital, Switzerland
[2]
MS Centre of Catalonia, Hospital Vall d'Hebron, Spain
[3]
Neurology Clinic, Heinrich-Heine-Universit?t, Germany
[4]
Service de Neurologie, Université of Rennes, France
[5]
Global Clinical Development, Bayer Pharma AG, Germany, Neurology Clinic, Heinrich-Heine-Universit?t
[6]
Department of Radiology and Nuclear Medicine, VU University Medical Centre, Netherlands
[7]
Institute of Neurology, National Hospital for Neurology and Neurosurgery, United Kingdom
[8]
Global Clinical Development, Bayer Pharma AG, Germany
[9]
Department of Medicine, Ottawa Hospital Research Institute, Canada
[10]
Global Medical Affairs, Bayer HealthCare Pharmaceuticals, United States
[11]
发布时间
2014-04-05
换一批
